Allianzs, Two-Sided

Allianz's Two-Sided Risk Picture: Costlier Claims Meet a Higher Jefferies Target

Published on 10/11/2026 at 11:10 | Editorial boerse-global.de

Allianz Commercial's claims study shows severity climbing ~30% a year, while Jefferies lifted its target to EUR 440 on India gains reinvested in bonds.

Geometrisches Bauhaus-Poster mit Schirm-Symbol und Schriftzug INSURANCE in Blau-Rot
Bauhaus-Poster mit Schriftzug INSURANCE steht sinnbildlich für die Branche von Allianz SE, ISIN DE0008404005 Illustration mit AI erstellt.

A pair of disclosures landed on the same day this week, and together they sketch the two forces Allianz investors will be weighing between now and the group's third-quarter results on 12 November 2026 — the rising cost of insuring businesses against interruption, and the redeployment of a windfall from India into fixed income.

Claims study: frequency isn't the story, severity is

Allianz Commercial published a review of 7,888 business-interruption claims spanning 1 January 2021 to 31 December 2025. The aggregate value of those claims came to roughly EUR 6.74 billion, with the average claim exceeding EUR 850,000.

The headline figure for anyone tracking the insurance book is the trajectory of that average: it has climbed by around 30% per year over the past two years. That is a severity measure — the cost of each individual loss — and it should not be confused with the number of cases captured in the study. The two metrics illuminate different things, one the accumulated claims volume, the other the more recent drift in cost per event.

The gap between interruption and property damage is where the economics bite. The average business-interruption loss ran about 70% higher than the associated average property damage. Fire and explosions alone accounted for more than 40% of the total analyzed claims value.

What the report does not do is forecast the group's profit. It describes a historical claims stock, not the outcome of the coming quarterly statement, and the distinction matters when reading it alongside anything resembling an earnings estimate.

Should investors sell immediately? Or is it worth buying Allianz?

Jefferies nudges its target, keeps its distance

On the investment side, Jefferies raised its price target on Allianz from EUR 420 to EUR 440 on Thursday, while leaving its rating at "Hold." Analyst Philip Kett tied the revision to realized gains from Allianz's Indian joint venture, which the insurer is ploughing back into fixed-income securities at an accelerated pace.

The higher target therefore rests on a specific capital-deployment argument rather than a broad upgrade in conviction — and the unchanged recommendation caps how much weight the adjustment can carry. Jefferies paired a loftier number with a neutral stance, and for shareholders that combination says more than the target in isolation.

Kett also flagged that persistent volatility in bond markets could produce losses on such paper at other insurers as well, a reminder that the reinvestment channel cuts both ways.

Friday's close of EUR 418.00 sat below the revised target, though that gap by itself settles nothing about the stock's appeal.

What the two threads actually tell you

Set side by side, the claims analysis and the analyst note present two distinct risk lenses: climbing costs per insured event, and the possibility of markdowns on a bond portfolio being built up with Indian proceeds. The India gains are a positive input; the reinvestment decision turns attention squarely toward where bond markets go next.

Neither thread yields a joint earnings projection, and neither substitutes for the company's own numbers. The 12 November 2026 report is the next hard data point — the moment when an industry-wide claims pattern, a capital-allocation thesis and the group's actual reported results can finally be compared on the same page. Until then, the EUR 440 target stands as an analyst's judgment, not a confirmed improvement in the quarterly figures.

Ad

Allianz Stock: New Analysis - 11 October

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

Disclaimer...

en | DE0008404005 | ALLIANZS | boerse | 70292262 |